Celadon Partners SPV 24 13D and 13G filings for Senti Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2025-03-17 3:01 pm Unchanged | 2025-03-06 | 13D | Senti Biosciences, Inc. SNTI | Celadon Partners SPV 24 | 9,777,000 37.600% | 0 (Unchanged) | Filing |
2025-03-13 4:31 pm Purchase | 2025-03-06 | 13D | Senti Biosciences, Inc. SNTI | Celadon Partners SPV 24 | 9,777,000 37.600% | 9,777,000![]() (New Position) | Filing |